Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000221368 | SCV000276806 | likely benign | Hereditary cancer-predisposing syndrome | 2019-03-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000235545 | SCV000293897 | uncertain significance | not provided | 2016-02-23 | criteria provided, single submitter | clinical testing | This variant is denoted MSH2 c.1077-3C>T or IVS6-3C>T and consists of a C>T nucleotide substitution at the -3 position of intron 6 of the MSH2 gene. Multiple in silico models predict this variant to weaken the nearby natural acceptor site, and to possibly cause abnormal gene splicing; however, in the absence of RNA or functional studies, the actual effect of this variant is unknown. This variant has not, to our knowledge, been published in the literature as pathogenic or benign. MSH2 c.1077-3C>T was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, suggesting it is not a common benign variant in these populations. The cytosine (C) nucleotide that is altered is not conserved across species. Based on currently available information, it is unclear whether MSH2 c.1077-3C>T is pathogenic or benign. |
Invitae | RCV000629733 | SCV000750689 | likely benign | Hereditary nonpolyposis colorectal neoplasms | 2023-12-09 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000221368 | SCV000903425 | likely benign | Hereditary cancer-predisposing syndrome | 2015-04-29 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV002267962 | SCV002552217 | uncertain significance | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV003150127 | SCV003838300 | uncertain significance | Breast and/or ovarian cancer | 2022-05-17 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV003997988 | SCV004815798 | likely benign | Lynch syndrome | 2023-12-15 | criteria provided, single submitter | clinical testing |